Abstract
Lysine specific demethylase 1 (LSD1) plays a vital role in epigenetic regulation of gene activation and repression in several human cancers and is recognized as a promising antitumor therapeutic target. In this paper, a series of 4-(4-benzyloxy)phenoxypiperidines were synthesized and evaluated. Among the tested compounds, compound 10d exhibited the potent and reversible inhibitory activity against LSD1 in vitro (IC50 = 4 μM). Molecular docking was conducted to predict its binding mode. Furthermore, 10d displayed it could inhibit migration of HCT-116 colon cancer cells and A549 lung cancer cells. Taken together, 10d deserves further investigation as a hit-to-lead for the treatment of LSD1 associated tumors.
Keywords:
Inhibitors; LSD1; Migration; Reversible; Selective.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Dose-Response Relationship, Drug
-
Drug Design*
-
Drug Screening Assays, Antitumor
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Histone Demethylases / antagonists & inhibitors*
-
Histone Demethylases / metabolism
-
Humans
-
Molecular Docking Simulation
-
Molecular Structure
-
Piperidines / chemical synthesis
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
-
Wound Healing / drug effects
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Piperidines
-
Histone Demethylases
-
KDM1A protein, human